A carregar...

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information

INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Insel, Philip S., Palmqvist, Sebastian, Mackin, R. Scott, Nosheny, Rachel L., Hansson, Oskar, Weiner, Michael W., Mattsson, Niklas
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045949/
https://ncbi.nlm.nih.gov/pubmed/27722193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.07.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!